≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Otosclerosis

DOID EFO Endpoint Browser PheWeb

H8_OTOSCLE

otosclerosis: Formation of spongy bone in the labyrinth capsule which can progress toward the stapes (stapedial fixation) or anteriorly toward the cochlea leading to conductive, sensorineural, or mixed hearing loss. Several genes are associated with familial otosclerosis with varied clinical signs.

Suggest a new description

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — H80
  • Hospital discharge: ICD-9 — 387
  • Hospital discharge: ICD-8 — 38699
  • Cause of death: ICD-10 — H80
  • Cause of death: ICD-9 — 387
  • Cause of death: ICD-8 — 38699

2 out of 7 registries used, show all original rules.

3018

4. Check minimum number of events

None

3018

5. Include endpoints

None

3018

6. Filter based on genotype QC (FinnGen only)

3018

Control definitions (FinnGen only)

Control exclude
H8_INNER

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
H80-H83
Name in latin
Otosclerosis

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 22316 13797 8374
Only index persons 20162 12689 7473
Unadjusted period prevalence (%)
Whole population 0.33 0.40 0.23
Only index persons 0.40 0.47 0.29
Median age at first event (years)
Whole population 46.35 46.34 46.36
Only index persons 45.60 45.55 45.69

-FinnGen-

Key figures

All Female Male
Number of individuals 3018 1916 1102
Unadjusted period prevalence (%) 0.59 0.65 0.49
Median age at first event (years) 45.51 44.37 47.48

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
2744
Matched controls
27440
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
H90.6
ICD-10 Finland
Mixed conductive and sensorineural hearing loss, bilateral
47.9
323.0
513
131
H80.9
ICD-10 Finland
Otosclerosis, unspecified
4412.8
323.0
1313
5
3870A
ICD-9 Finland
Otosclerosis involving oval window, nonobliterative
+∞
323.0
488
*
38699
ICD-8 Finland
NA
+∞
323.0
552
*
Z01.1
ICD-10 Finland
Examination of ears and hearing
7.0
323.0
954
1930
DFF00
NOMESCO Finland
Pure tone audiometry
9.0
323.0
763
1126
H80.1
ICD-10 Finland
Otosclerosis involving oval window, obliterative
+∞
323.0
377
*
4133
FHL
Stapedectomy sampling
2155.6
323.0
395
*
H90.1
ICD-10 Finland
Conductive hearing loss, unilateral with unrestricted hearing on the contralateral side
47.8
323.0
457
114
H80.0
ICD-10 Finland
Otosclerosis involving oval window, nonobliterative
16384.0
323.0
1366
*
DDA00
NOMESCO Finland
Stapedotomy
+∞
323.0
995
*
ZXC10
NOMESCO Finland
Use of laser
40.2
323.0
573
179
H80.8
ICD-10 Finland
Other otosclerosis
2538.0
255.0
243
*
H90.3
ICD-10 Finland
Sensorineural hearing loss, bilateral
4.9
228.6
905
2503
H90.7
ICD-10 Finland
Mixed conductive and sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side
31.3
227.6
307
110
DDB00
NOMESCO Finland
Stapedectomy
+∞
227.3
215
*
UDC00
NOMESCO Finland
Ear microscopy
6.6
175.2
493
878
H80
ICD-10 Finland
Otosclerosis
+∞
168.5
160
*
Z46.1
ICD-10 Finland
Fitting and adjustment of hearing aid
6.6
155.5
434
757
H90.0
ICD-10 Finland
Conductive hearing loss, bilateral
34.3
148.4
195
61
Z97.4
ICD-10 Finland
Presence of external hearing-aid
7.3
129.8
332
506
Z3229
NOMESCO Finland
Other healthcare associate professional
4.6
121.5
468
1169
DC1AD
NOMESCO Finland
Temporalbone CT
23.3
119.9
175
80
DFF15
NOMESCO Finland
Speech audiometry
6.9
111.2
295
470
R5130
NOMESCO Finland
Repair work or maintenance done on the aid
8.7
108.2
245
306
DAX00
NOMESCO Finland
Adjustment or review of hearing aid
6.7
101.1
274
448
R5120
NOMESCO Finland
Preparation of an aid
8.7
90.6
204
251
H81.0
ICD-10 Finland
Ménière disease
35.0
75.3
98
29
H80.20
ICD-10 Finland
Otosclerosis involving round window
+∞
73.2
70
*
YPA00
NOMESCO Finland
Excision of blood vessel for transplantation
+∞
73.2
70
*
H02
ICPC
Hearing complaint
2.9
66.1
448
1711
4139
FHL
Other measure in this category
+∞
64.8
62
*
H90.4
ICD-10 Finland
Sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side
5.6
64.3
199
381
DAX08
NOMESCO Finland
Fitting of hearing aid
4.9
58.7
205
449
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
2.7
58.0
436
1764
DDW99
NOMESCO Finland
Other operation on ossicles of ear
+∞
57.5
55
*
H91.9
ICD-10 Finland
Hearing loss, unspecified
4.6
55.6
205
475
N07CA01
ATC
betahistine; oral
3.6
54.8
272
823
DFF10
NOMESCO Finland
Measurement of acoustic impedance (tympanometry and reflex testing)
41.6
52.1
65
16
DFF30
NOMESCO Finland
Loudness discomfort Level (LDL)
6.2
50.5
141
237
4134
FHL
Interposition, removal of the disk and placing at least another column on top of the window
+∞
50.1
48
*
H90.8
ICD-10 Finland
Mixed conductive and sensorineural hearing loss, unspecified
18.8
44.1
68
37
DCD10
NOMESCO Finland
Tympanoplasty
28.4
39.1
53
19
DCA30
NOMESCO Finland
Exploration of middle ear
87.4
38.9
43
5
R5140
NOMESCO Finland
Monitoring the use of the aid
2.4
35.6
328
1462
H81.3
ICD-10 Finland
Other peripheral vertigo
8.0
32.6
75
96
H80.28
ICD-10 Finland
Cochlear otosclerosis
+∞
32.3
31
*
H81.1
ICD-10 Finland
Benign paroxysmal vertigo
2.9
30.0
188
669
SPAT1043
SPAT
Audiometry
2.2
27.8
308
1493
DFE00
NOMESCO Finland
Insertion of cochlear implant
21.4
26.1
38
18
DDD05
NOMESCO Finland
Plastic repair of ossicular chain
262.9
25.7
26
*
H90.2
ICD-10 Finland
Conductive hearing loss, unspecified
14.2
24.8
42
30
H81.2
ICD-10 Finland
Vestibular neuronitis
24.5
24.4
34
14
H74.2
ICD-10 Finland
Discontinuity and dislocation of ear ossicles
48.8
24.3
29
6
H71
ICD-10 Finland
Cholesteatoma of middle ear
7.8
24.2
56
73
H93.1
ICD-10 Finland
Tinnitus
2.5
23.9
200
844
4150
FHL
Tympanoplasty (including for reasons other than inflammation)
35.3
22.0
28
8
DCB10
NOMESCO Finland
Freeing of adhesions of middle ear
115.9
21.6
23
*
H74.3
ICD-10 Finland
Other acquired abnormalities of ear ossicles
50.4
21.1
25
5
ZXA05
NOMESCO Finland
Left side
1.6
19.6
672
4702
ZXA00
NOMESCO Finland
Right side
1.5
19.5
719
5118
DFX00
NOMESCO Finland
Connecting cochlear implant
23.8
18.6
26
11
Z97.8
ICD-10 Finland
Presence of other specified devices
15.4
17.9
29
19
TDA90
NOMESCO Finland
Removal wax from ear
5.0
17.9
57
115
H80.2
ICD-10 Finland
Cochlear otosclerosis
+∞
17.7
17
*
WX002
NOMESCO Finland
Sedation and analgesia
1.6
17.4
519
3494
RK520
NOMESCO Finland
NA
9.8
17.1
34
35
H91.1
ICD-10 Finland
Presbycusis
2.4
16.8
149
650
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.1
16.0
180
874
DFF16
NOMESCO Finland
Speech-in-noise audiometry
21.1
16.0
23
11
DDA10
NOMESCO Finland
Exploration of ossicular chain
+∞
15.6
15
*
DDD10
NOMESCO Finland
Interposition between malleus and stapes
45.2
15.1
18
*
TDW99
NOMESCO Finland
Other minor procedure in surgery of ear, nose and larynx
2.8
14.9
98
363
4161
FHL
Exploratory tympanotomy
57.0
14.8
17
*
DE2CG
NOMESCO Finland
Acoustic channel extensive MRI examination with high intensity magnet
4.8
14.7
48
101
DEA10
NOMESCO Finland
Attico-antrotomy
21.1
14.6
21
10
WX110
NOMESCO Finland
Local anesthesy
1.4
14.5
1677
14611
RK110
NOMESCO Finland
NA
6.1
13.9
37
61
H74.1
ICD-10 Finland
Adhesive middle ear disease
15.8
13.9
22
14
H29
ICPC
Ear symptom/complaint other
1.8
13.9
254
1482
RK320
NOMESCO Finland
NA
5.6
13.6
39
71
DFF59
NOMESCO Finland
Other assessment of balance
7.0
13.3
32
46
ZXD20
NOMESCO Finland
Day surgery
1.6
13.0
327
2095
RK420
NOMESCO Finland
NA
22.6
12.9
18
8
DCA10
NOMESCO Finland
Paracentesis of tympanic membrane
4.3
12.6
46
109
H83.1
ICD-10 Finland
Labyrinthine fistula
+∞
12.5
12
*
ZXD10
NOMESCO Finland
Scheduled procedure
1.4
12.4
950
7663
DCA20
NOMESCO Finland
Insertion of ventilating tube through tympanic membrane
4.1
12.4
47
116
3890A
ICD-9 Finland
Deafness, Conductive deafness
37.7
12.2
15
*
R4135
NOMESCO Finland
Rehabilitation for hearing problems
3.5
12.0
54
155
H72.0
ICD-10 Finland
Central perforation of tympanic membrane
3.3
11.7
57
174
1450
FHL
Otomicroscopy
12.6
11.6
20
16
H28
ICPC
Limited function/disability (H)
4.5
11.6
40
90
H83
ICPC
Otosclerosis
+∞
11.5
11
*
ZXE10
NOMESCO Finland
More than one and less than three hours
1.4
11.4
891
7192
Q78.00
ICD-10 Finland
Congenital osteogenesis imperfecta
35.2
11.3
14
*
DCD00
NOMESCO Finland
Myringoplasty
5.6
11.0
31
56
R42
ICD-10 Finland
Dizziness and giddiness
1.5
10.7
458
3313
Z45.3
ICD-10 Finland
Adjustment and management of implanted hearing device
60.2
10.6
12
*
H91.2
ICD-10 Finland
Sudden idiopathic hearing loss
3.0
10.0
57
193
DBD20
NOMESCO Finland
Plastic repair of external auditory canal
7.5
9.4
21
28
SPAT1352
SPAT
Inspection, maintenance and instruction for use of hearing aid
3.5
8.6
38
109
ZXE00
NOMESCO Finland
One hour or less
1.3
8.5
919
7693
H60.9
ICD-10 Finland
Otitis externa, unspecified
1.8
8.4
145
833
Q16.3
ICD-10 Finland
Congenital malformation of ear ossicles
+∞
8.3
8
*
DDD00
NOMESCO Finland
Mobilisation of stapes
+∞
8.3
8
*
H60.3
ICD-10 Finland
Other infective otitis externa
2.6
8.0
55
212
R4160
NOMESCO Finland
Other therapy enhancing rehabilitation
2.8
8.0
48
173
RK120
NOMESCO Finland
NA
7.2
7.9
18
25
H91
ICD-10 Finland
Other hearing loss
4.1
7.9
29
72
SPAT1033
SPAT
Irrigation or wax removal of outer auditory canal
1.4
7.8
425
3204
H91.8
ICD-10 Finland
Other specified hearing loss
4.0
7.4
28
71
\1
NOMESCO Finland
NA
80.3
7.4
8
*
4132
FHL
Crurotomy, fork truncation, and partial removal of the tripod plate
+∞
7.3
7
*
DCW99
NOMESCO Finland
Other operation on eardrum and middle ear
15.8
7.2
11
7
Z96.2
ICD-10 Finland
Presence of otological and audiological implants
15.8
7.2
11
7
SPAT1041
SPAT
Comprehensive hearing test
3.1
7.2
36
116
UDC10
NOMESCO Finland
Tympanoscopy
20.1
7.1
10
5
R1100
NOMESCO Finland
General evaluation of the need for rehabilitation
4.5
7.1
23
51
XX7FW
NOMESCO Finland
NA
10.9
6.8
12
11
RL210
NOMESCO Finland
NA
5.3
6.8
19
36
38990
ICD-8 Finland
Other deafness, Partialis uni-sive bilateralis
22.6
6.7
9
*
R5599
NOMESCO Finland
Other rehabilitation service
2.2
6.6
62
284
R1210
NOMESCO Finland
Medical assessment of need and possibilities to rehabilitation
3.5
6.4
27
77
H66.0
ICD-10 Finland
Acute suppurative otitis media
1.8
6.3
109
631
DC1AI
NOMESCO Finland
Cone beam CT of ear
18.0
6.3
9
5
DE2BG
NOMESCO Finland
Acoustic channel MRI examination with high intensity magnet
3.3
6.3
29
89
DDD20
NOMESCO Finland
Interposition between eardrum and footplate of stapes
+∞
6.2
6
*
RK530
NOMESCO Finland
NA
26.7
6.2
8
*
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
1.2
6.1
1015
8854
H65.3
ICD-10 Finland
Chronic mucoid otitis media
2.7
6.1
37
136
H81
ICPC
Excessive ear wax
1.4
6.1
344
2609

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
413
3231
1.32
6.15
4.7
4.6
%
34.0
32.8
1.32
270
2160
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
2759
26758
1.36
5.31
10.8
10.8
u/l
25.5
25.8
0.23
2642
25784
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
2431
23222
1.24
5.13
5.0
4.9
mu/l
1.9
2.1
0.97
2193
21185
(3013707) Erythrocyte sedimentation rate by Westergren method
2000
18879
1.18
4.21
4.3
4.2
mm/h
12.0
12.8
1.90
1829
17432
(3010813) Leukocytes [#/volume] in Blood
2833
27709
1.37
4.08
20.7
21.7
e9/l
6.6
6.7
2.61
2743
26883
(3024731) MCV [Entitic volume]
2832
27701
1.36
4.05
20.6
21.6
fl
91.2
91.3
0.25
2782
27277
(3007461) Platelets [#/volume] in Blood
2831
27691
1.36
4.04
20.7
21.7
e9/l
250.2
252.5
1.11
2740
26960
(3035941) MCH [Entitic mass]
2832
27703
1.36
4.03
20.6
21.6
pg
30.4
30.3
0.42
2782
27277
(3026361) Erythrocytes [#/volume] in Blood
2832
27705
1.36
4.01
20.7
21.7
e12/l
4.5
4.5
0.89
2739
26879
(3000963) Hemoglobin [Mass/volume] in Blood
2832
27712
1.36
3.94
20.8
21.8
g/l
134.9
134.3
1.55
2782
27287
(3019550) Sodium [Moles/volume] in Serum or Plasma
2684
26093
1.26
3.82
16.1
16.9
mmol/l
139.9
139.7
3.23
2613
25441
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
788
6961
1.18
3.75
1.7
1.6
mmol/l
1.3
1.4
0.56
655
5824
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
1563
14547
1.15
3.74
2.8
2.7
—
—
—
0
0
(3019225) pH of Specimen
327
2649
1.26
3.73
4.1
4.5
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
2627
25495
1.23
3.69
5.2
5.1
mmol/l
2.8
2.8
1.30
2375
23395
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
2435
23475
1.19
3.57
5.7
5.9
mmol/mol
39.1
39.9
5.29
2212
21654
(3013512) EKG study
848
7579
1.17
3.45
4.0
3.9
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
2338
22484
1.18
3.43
15.4
15.7
%
39.7
39.4
1.05
1636
15696
(3023103) Potassium [Moles/volume] in Serum or Plasma
2686
26172
1.24
3.35
16.4
17.0
mmol/l
4.0
4.0
0.28
2612
25482
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
2577
25009
1.21
3.33
4.7
4.5
mmol/l
4.7
4.7
0.45
2334
23086
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
69
1053
0.65
3.22
2.1
2.0
ug/l
4.9
2.4
0.73
58
941
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
1275
11809
1.14
3.05
5.9
6.1
mmol/l
1.2
1.2
3.46
1125
10692
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
54
330
1.65
3.04
2.1
2.2
mg/l
26.3
22.2
0.23
15
83
(3037467) Urinalysis macro (dipstick) panel - Urine
1825
17316
1.14
2.96
4.5
4.4
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
2554
24824
1.19
2.93
4.7
4.5
mmol/l
1.5
1.5
0.68
2299
22779
(36660697) Celiac disease serology panel - Serum
234
1889
1.26
2.80
1.1
1.2
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
2470
23978
1.17
2.70
4.1
4.0
mmol/l
1.3
1.3
1.99
2213
21832
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
2535
24677
1.17
2.59
4.8
4.7
mmol/l
5.9
6.0
4.26
2271
22445
(42870588) Differential panel, method unspecified - Blood
939
8608
1.13
2.54
5.9
5.9
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
1382
12977
1.12
2.48
6.7
6.9
mmol/l
1.2
1.2
3.63
1145
10952
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
496
4366
1.16
2.41
1.3
1.3
iu/ml
30.3
35.1
0.44
147
1384
(40761511) CBC panel - Blood by Automated count
2658
26006
1.19
2.39
13.5
13.9
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
1136
10604
1.11
2.19
2.0
2.0
pmol/l
98.5
95.5
1.25
582
5354
(4034850)
58
839
0.69
2.18
9.8
10.2
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
187
1522
1.24
2.15
1.3
1.3
au/ml
29.4
49.3
—
7
75
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
29
168
1.73
2.07
1.6
1.9
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
204
1685
1.23
2.05
2.4
2.4
au/ml
13.2
25.0
—
6
81
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
244
2885
0.83
2.04
1.7
1.8
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
488
5452
0.87
1.99
4.3
4.6
—
—
—
0
0
(3036782) Glucose [Moles/volume] in Pleural fluid
12
256
0.47
1.94
1.3
1.5
mmol/l
6.4
6.4
0.01
12
241
(3022689) Creatine [Moles/volume] in Urine
15
72
2.09
1.86
1.5
1.5
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
2025
19573
1.11
1.84
4.2
4.1
pmol/l
14.7
14.8
1.34
1819
17749
(3004616) Nuclear Ab [Presence] in Serum
46
310
1.49
1.83
1.4
1.2
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
50
344
1.46
1.80
1.6
1.5
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
609
6662
0.89
1.76
1.4
1.4
—
—
—
0
0
(3035880) pH of Pleural fluid
6
152
0.39
1.76
1.5
1.4
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
50
347
1.45
1.73
1.6
1.5
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
248
2882
0.85
1.73
1.7
1.7
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
2051
19873
1.10
1.69
7.5
7.7
u/l
79.5
78.8
0.21
1905
18709
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
49
341
1.44
1.68
1.6
1.5
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
49
341
1.44
1.68
1.6
1.5
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
49
342
1.44
1.66
1.6
1.5
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
533
4839
1.12
1.65
1.7
1.8
nmol/l
1031.4
1190.8
4.28
384
3639
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
50
351
1.43
1.65
1.6
1.5
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
119
1474
0.80
1.62
4.0
3.6
u/ml
104.4
62.9
0.45
114
1422
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
462
4164
1.13
1.62
1.3
1.2
u/ml
10.8
12.5
0.21
174
1593
(3037522) Nuclear Ab [Titer] in Serum
374
3327
1.14
1.61
1.4
1.3
titre
501.7
535.4
0.15
81
734
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
21
121
1.74
1.58
1.2
1.1
—
—
—
0
0
(4094501)
90
700
1.29
1.57
1.2
1.1
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
298
2614
1.16
1.57
1.6
1.6
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
38
256
1.49
1.55
1.8
1.4
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
58
783
0.74
1.54
1.5
1.5
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
1122
10617
1.09
1.52
2.1
2.1
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
510
4642
1.12
1.52
1.5
1.5
g/l
2.5
2.5
0.07
304
2782
(3023323) Follitropin [Units/volume] in Serum or Plasma
112
900
1.25
1.52
1.4
1.4
iu/l
41.3
34.0
1.22
103
769
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
90
704
1.29
1.52
1.2
1.2
u/ml
6.3
44.2
—
8
39
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
45
629
0.71
1.48
2.6
2.3
ug/min
156.3
102.8
0.28
30
381
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
1137
11968
0.92
1.45
3.6
4.0
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
83
648
1.29
1.43
1.2
1.2
u/ml
5.8
7.6
—
7
70
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
178
2087
0.84
1.42
2.6
2.7
ml/min/173m2
66.4
64.6
0.28
71
847
(3026008) Bacteria identified in Urine by Culture
846
7938
1.09
1.38
3.1
3.2
—
—
—
0
0
(40768443) Skin Pathology biopsy report
136
1131
1.21
1.37
1.1
1.2
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
16
274
0.58
1.37
1.5
1.5
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
321
2865
1.13
1.34
2.1
2.2
ug/g
128.4
137.3
0.14
237
2226
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
375
4151
0.89
1.34
1.9
1.8
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
573
5286
1.10
1.34
1.3
1.2
u/ml
1.5
1.8
0.20
134
1375
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
11
208
0.53
1.32
2.2
1.7
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
747
6982
1.09
1.32
5.3
5.0
ug/l
2.1
3.0
2.71
652
6243
(21494755) Public health laboratory ask at order entry panel
218
1896
1.16
1.32
1.4
1.4
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
0
41
0.00
1.31
0.0
1.2
—
—
—
0
0
(3019060) Gas panel - Arterial blood
144
1703
0.84
1.29
5.2
5.2
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
9
174
0.52
1.28
1.0
1.1
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
83
659
1.27
1.28
1.2
1.2
u/ml
5.6
8.4
0.51
14
112
(40761539) Cells [Type] in Urine sediment by Light microscopy
13
69
1.89
1.28
1.0
1.1
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
2432
23862
1.10
1.28
13.3
13.7
ml/min/173m2
78.9
78.9
0.05
2027
19716
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
8
35
2.29
1.26
1.1
1.1
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
28
186
1.51
1.26
1.1
1.2
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
200
1740
1.16
1.22
2.4
3.1
e9/l
4.0
4.0
0.01
147
1355
(3025159) Blasts/100 leukocytes in Blood
166
1929
0.85
1.22
4.5
4.2
%
0.0
0.4
0.98
40
488
(3023410) Appearance of Cerebral spinal fluid
35
246
1.43
1.21
1.7
1.5
—
—
—
0
0
(40761535) Cells panel - Urine sediment
185
2127
0.86
1.19
3.9
3.5
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
713
6686
1.09
1.17
2.8
2.7
umol/l
3952.5
5647.1
0.53
613
5791
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
6
126
0.48
1.16
1.3
1.3
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
33
0.00
1.16
0.0
1.0
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
824
7778
1.08
1.15
2.0
2.1
u/l
149.8
213.9
3.13
765
7281
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
139
1181
1.19
1.15
1.0
1.0
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
94
769
1.23
1.15
1.6
1.8
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
309
3424
0.89
1.15
5.7
6.0
mmol/l
1.0
1.0
1.23
294
3177
(3023419) Bacteria identified in Sputum by Culture
23
344
0.67
1.14
4.6
2.6
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
622
6652
0.92
1.13
4.2
4.2
estimate
0.0
0.0
0.14
202
2213
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
49
642
0.76
1.13
1.2
1.6
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
654
6976
0.92
1.12
4.1
4.4
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
22
330
0.66
1.12
1.0
1.1
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
1229
11789
1.07
1.11
5.9
6.1
%
2.8
2.9
0.67
1132
10972
(3003740) Influenza virus B Ag [Presence] in Specimen
22
329
0.67
1.10
1.0
1.1
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
32
226
1.42
1.10
1.1
1.2
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
17
104
1.64
1.09
1.2
1.2
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
333
3026
1.11
1.07
1.6
1.5
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
38
511
0.74
1.06
1.3
1.7
nmol/l
0.8
0.8
0.07
30
420
(1002224) Polysomnography panel
110
924
1.20
1.05
1.1
1.1
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
191
2167
0.87
1.05
2.4
2.6
e9/l
71.2
70.5
0.08
140
1649
(3003434) Protein [Mass/volume] in Pleural fluid
25
360
0.69
1.04
1.5
1.5
g/l
31.1
32.3
0.20
25
326
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
27
187
1.45
1.03
1.1
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
27
187
1.45
1.03
1.1
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
27
187
1.45
1.03
1.1
1.1
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
1119
10722
1.07
1.03
2.3
2.3
nmol/l
79.6
78.8
0.47
989
9613
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
9
47
1.92
1.02
1.0
1.1
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
217
1929
1.13
1.02
1.7
1.8
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
60
753
0.79
1.01
1.2
1.2
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
1232
11850
1.07
1.00
6.1
6.4
%
8.7
8.7
0.05
1134
11079
(44790048)
20
298
0.67
1.00
1.6
1.5
—
—
—
0
0
(44790047)
20
298
0.67
1.00
1.6
1.5
—
—
—
0
0
(44790049)
20
298
0.67
1.00
1.6
1.5
—
—
—
0
0
(44806118)
20
298
0.67
1.00
1.6
1.5
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
12
68
1.77
1.00
2.6
2.5
—
—
—
0
0
(3020891) Body temperature
87
1047
0.83
0.99
5.3
4.4
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
1192
11458
1.07
0.99
6.0
6.1
%
0.7
0.7
0.17
1094
10672
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
15
237
0.63
0.99
1.3
1.4
u/l
301.3
328.5
0.13
15
231
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
35
470
0.74
0.98
1.3
1.5
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
5
23
2.18
0.98
1.2
1.0
—
—
—
0
0
(44786800) Granulocytes/100 leukocytes in Body fluid
0
29
0.00
0.97
0.0
1.4
—
21.9
—
0
18
(3009015) Lactate [Moles/volume] in Synovial fluid
0
29
0.00
0.97
0.0
1.3
—
6.1
—
0
17
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
69
848
0.81
0.97
3.4
3.2
u/ml
0.3
0.4
0.43
38
490
(3001122) Ferritin [Mass/volume] in Serum or Plasma
1088
10434
1.07
0.97
2.7
2.8
ug/l
135.7
129.5
0.24
995
9634
(21491868) Cryoglobulin [Mass/volume] in Serum
16
100
1.60
0.96
1.0
1.3
g/l
—
0.2
—
0
11
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
400
3694
1.10
0.95
1.4
1.4
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
60
746
0.80
0.95
1.2
1.1
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
15
234
0.64
0.94
1.0
1.0
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
7
37
1.89
0.94
9.1
4.4
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
1668
16223
1.06
0.94
3.1
3.1
u/l
49.1
50.5
0.25
1546
15016
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
19
125
1.52
0.94
2.2
1.7
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
112
955
1.18
0.93
2.5
2.5
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
22
150
1.47
0.92
1.0
1.1
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
184
1632
1.14
0.91
1.2
1.2
iu/ml
115.4
153.5
0.81
65
601
(3017143) Hepatitis C virus Ab [Presence] in Serum
223
2478
0.89
0.91
1.6
1.6
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
499
5333
0.92
0.91
2.8
2.6
e6/l
4.9
5.9
1.53
417
4650
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
60
741
0.81
0.90
1.2
1.1
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
140
1602
0.87
0.90
6.3
7.3
mmol/l
24.7
24.6
0.20
129
1493
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
31
417
0.74
0.90
1.3
1.5
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
26
185
1.41
0.89
1.2
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
26
185
1.41
0.89
1.2
1.2
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
52
651
0.80
0.89
1.6
1.8
iu/l
2.8
4.9
3.82
20
221
(3021788) Differential panel - Synovial fluid
59
475
1.25
0.88
1.6
1.5
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
26
186
1.40
0.87
1.2
1.2
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
194
2165
0.89
0.86
4.3
4.1
%
1.1
0.9
0.32
52
627
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
36
273
1.32
0.85
1.2
1.4
u/l
30.7
31.2
0.04
30
228
(4015189)
12
72
1.67
0.85
3.1
2.3
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
17
112
1.52
0.84
2.6
1.9
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
17
112
1.52
0.84
2.6
1.9
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
20
286
0.70
0.84
1.4
1.4
e6/l
75614.9
85091.1
0.06
11
171
(3002030) Lymphocytes/100 leukocytes in Blood
1256
12143
1.06
0.84
6.0
6.2
%
27.9
27.8
0.15
1149
11289
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
10
57
1.76
0.83
1.4
1.3
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
2107
20677
1.06
0.83
17.0
17.9
%
13.7
13.7
1.05
2072
20192
(3002179) Metamyelocytes/100 leukocytes in Blood
175
1959
0.89
0.82
4.3
3.9
%
0.6
0.6
0.05
36
447
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
17
113
1.51
0.82
2.6
1.9
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
28
375
0.74
0.81
1.4
1.5
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
52
642
0.81
0.80
1.5
1.3
—
—
—
0
0
(3000034) Microalbumin [Mass/volume] in Urine
32
241
1.33
0.80
3.2
2.9
mg/l
25.5
35.5
0.22
27
174
(3011288) Drugs identified in Urine by Screen method
42
329
1.28
0.80
1.6
2.0
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
18
122
1.48
0.80
1.4
1.4
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
18
122
1.48
0.80
1.4
1.4
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
6
33
1.82
0.79
1.2
1.1
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
16
235
0.68
0.79
1.6
1.5
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
631
5985
1.07
0.78
1.5
1.6
nmol/l
20.6
20.8
0.15
515
5099
(3014111) Lactate [Moles/volume] in Serum or Plasma
201
2223
0.90
0.78
8.2
6.8
mmol/l
1.3
1.4
0.70
195
2140
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
25
182
1.38
0.77
1.5
1.6
u/l
9.5
6.7
0.26
13
90
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
199
2201
0.90
0.77
3.8
4.1
mmol/l
1.2
1.2
0.52
166
1920
(40768795) Lymph node Pathology biopsy report
35
269
1.30
0.77
1.1
1.2
—
—
—
0
0
(3019420) Tryptase [Mass/volume] in Serum or Plasma
18
123
1.47
0.77
1.2
1.5
ug/l
6.9
8.1
0.31
18
104
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
7
125
0.56
0.77
9.0
11.8
nmol/l
137911.7
879.2
—
7
120
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
63
521
1.21
0.76
1.2
1.2
u/ml
50.3
44.5
—
9
59
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
17
115
1.48
0.76
1.4
1.3
—
—
—
0
0
(3022145) Colonoscopy Study observation
311
2873
1.09
0.76
1.3
1.3
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
623
6559
0.94
0.76
4.1
3.9
%
91.1
90.5
0.24
615
6386
(3018010) Neutrophils/100 leukocytes in Blood
1235
11962
1.05
0.76
5.8
6.0
%
57.1
57.3
0.18
1136
11165
(3027945) Reticulocytes/100 erythrocytes in Blood
266
2894
0.91
0.75
2.0
2.6
%
1.8
1.8
0.07
232
2575
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
14
209
0.67
0.75
1.7
1.6
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
78
660
1.19
0.75
1.8
2.0
mg/l
11.1
11.8
0.38
72
606
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
33
426
0.77
0.75
1.2
1.2
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
20
141
1.42
0.74
1.1
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
20
141
1.42
0.74
1.1
1.0
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
2533
25039
1.07
0.73
13.9
14.7
mg/l
22.5
23.9
1.33
1986
19888
(3044290) Cell count panel - Cerebral spinal fluid
59
488
1.21
0.73
1.6
1.4
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
50
611
0.82
0.72
1.9
2.2
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
606
6373
0.94
0.72
2.2
2.2
mg/l
2.9
3.0
0.38
506
5420
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
22
159
1.39
0.72
1.3
1.4
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
10
60
1.67
0.72
1.0
1.1
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
7
40
1.75
0.71
1.7
2.2
umol/l
13.3
16.7
—
7
40
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
5
26
1.92
0.70
1.0
1.0
—
—
—
0
0
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
12
182
0.66
0.70
1.3
1.3
u/l
13.8
11.8
0.27
12
170
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
268
2903
0.92
0.70
1.6
1.6
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
100
870
1.15
0.70
1.5
1.7
mg/l
2.5
3.9
1.02
71
623
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
231
2519
0.91
0.70
2.4
2.2
g/l
0.2
0.2
0.14
219
2364
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
22
160
1.38
0.70
1.3
1.4
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
18
126
1.43
0.70
9.4
13.0
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
9
58
1.55
0.69
1.0
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
9
58
1.55
0.69
1.0
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
9
58
1.55
0.69
1.0
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
9
58
1.55
0.69
1.0
1.1
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
9
143
0.63
0.69
1.2
1.1
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
12
181
0.66
0.69
1.2
1.6
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
24
319
0.75
0.68
1.4
1.5
e6/l
1570.6
2202.1
0.49
19
235
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
5
27
1.85
0.68
5.4
4.5
—
—
—
0
0
(3003129) Base excess in Capillary blood by calculation
10
61
1.64
0.68
1.2
1.9
mmol/l
0.8
1.6
—
10
55
(3022621) pH of Urine by Test strip
152
1691
0.89
0.68
3.1
3.1
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
16
227
0.70
0.68
1.6
1.4
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
7
118
0.59
0.67
3.0
3.8
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
54
649
0.83
0.67
1.9
1.6
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
16
226
0.71
0.66
1.6
1.4
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
52
626
0.83
0.66
1.2
1.2
—
—
—
0
0
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
12
179
0.67
0.66
1.4
1.4
u/l
11.8
13.4
0.82
12
173
(3051387) C reactive protein [Mass/volume] in Capillary blood
45
549
0.82
0.66
5.2
3.5
mg/l
27.0
27.6
0.04
27
342
(3021440) Promyelocytes/100 leukocytes in Blood
187
2051
0.91
0.65
4.4
4.2
%
0.1
0.1
0.48
49
571
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
11
70
1.57
0.65
1.1
1.1
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
41
331
1.24
0.65
1.6
1.3
nmol/l
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
66
560
1.18
0.64
1.3
1.3
miu/ml
224.2
225.2
0.01
24
247
(3010421) pH of Blood
60
709
0.84
0.63
6.0
4.5
ph
7.4
7.4
1.21
48
588
(3032080) INR in Blood by Coagulation assay
1070
10370
1.05
0.63
8.7
9.3
inr
1.2
1.3
0.24
270
2964
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
204
2223
0.91
0.63
2.4
2.3
ug/l
8.3
7.1
0.27
172
1971
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
14
200
0.70
0.62
1.2
1.2
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
150
1353
1.11
0.62
9.2
9.3
mmol/l
24.1
24.4
0.59
140
1267
(4010399)
199
1822
1.10
0.62
1.4
1.4
—
—
—
0
0
(4024509)
33
261
1.27
0.62
1.5
1.7
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
38
306
1.24
0.62
1.7
1.4
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
53
631
0.84
0.61
1.9
1.7
—
—
—
0
0
(3022313) Gas panel - Capillary blood
125
1117
1.12
0.61
3.5
3.9
—
—
—
0
0
(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay
6
105
0.57
0.61
1.0
1.1
%
101.2
92.8
—
6
85
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
22
290
0.76
0.61
1.5
1.5
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
108
957
1.13
0.61
3.6
4.0
mmol/l
25.0
24.9
0.03
101
890
(3000492) Spirometry study
253
2346
1.09
0.60
1.4
1.5
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
0
20
0.00
0.60
0.0
1.5
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
0
20
0.00
0.60
0.0
1.1
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
20
0.00
0.60
0.0
1.1
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
22
165
1.34
0.60
2.5
2.4
e6/l
616.1
728.0
0.38
12
68
(3019150) Specific gravity of Urine by Refractometry
514
5397
0.94
0.60
4.1
4.2
kg/l
1.0
1.0
0.34
69
793
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
12
80
1.50
0.59
1.0
1.1
—
—
—
0
0
(3010838) Calcium [Moles/time] in 24 hour Urine
20
148
1.35
0.59
1.2
1.8
—
10.1
—
0
7
(3017817) Protein [Mass] in Urine collected for unspecified duration
17
232
0.73
0.59
2.0
2.3
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
22
0.00
0.59
0.0
1.1
—
—
—
0
0
(3012501) Base excess in Blood by calculation
50
595
0.84
0.58
6.6
4.7
mmol/l
2.8
2.7
0.09
32
416
(3008898) HLA-B27 [Presence]
84
734
1.15
0.58
1.0
1.1
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
151
1369
1.11
0.58
1.2
1.3
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
23
0.00
0.58
0.0
1.0
—
—
—
0
0
(3011897) Casein IgE Ab [Units/volume] in Serum
0
23
0.00
0.58
0.0
1.1
—
0.2
—
0
5
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
19
140
1.36
0.58
2.7
1.8
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
19
140
1.36
0.58
2.7
1.8
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
19
140
1.36
0.58
2.7
1.8
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
19
140
1.36
0.58
2.7
1.8
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
37
300
1.24
0.58
1.2
1.2
u/l
57.9
56.4
0.07
24
210
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
27
343
0.79
0.58
4.3
2.3
u/ml
182.5
924.1
0.46
27
332
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
79
688
1.15
0.58
1.5
1.4
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
45
540
0.83
0.58
3.7
3.2
nmol/l
0.8
0.8
0.23
35
411
(40768806) Pleura Pathology biopsy report
22
287
0.76
0.57
1.5
1.6
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
59
502
1.18
0.57
1.2
1.6
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
6
35
1.72
0.57
1.0
1.0
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
738
7663
0.95
0.57
3.4
3.2
e6/l
36.8
77.4
1.59
545
5872
(3004716) Salmonella sp identified in Stool by Organism specific culture
104
1168
0.89
0.57
1.5
1.3
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
16
115
1.39
0.56
1.4
1.4
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
788
8164
0.95
0.56
2.2
2.4
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
5
86
0.58
0.56
1.0
1.1
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
8
55
1.46
0.56
1.5
2.2
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
5
88
0.57
0.56
3.0
2.1
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
24
185
1.30
0.56
1.6
1.6
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
6
37
1.62
0.55
1.0
1.3
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
864
8929
0.95
0.55
3.9
3.7
e6/l
119.4
108.6
0.09
584
6329
(4281824)
24
307
0.78
0.55
1.1
1.2
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
59
505
1.17
0.54
1.2
1.6
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
8
125
0.64
0.54
1.8
1.2
—
—
—
0
0
(3022493) Free Hemoglobin [Mass/volume] in Plasma
14
99
1.42
0.54
2.6
7.2
mg/l
121.5
63.1
—
8
71
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
14
99
1.42
0.54
1.3
1.1
iu/ml
139.8
191.5
0.55
14
99
(40758292) HTLV I+II Ab panel - Serum
6
39
1.54
0.53
1.7
1.5
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
6
39
1.54
0.53
1.2
1.2
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
348
3287
1.07
0.53
27.4
24.6
inr
1.4
1.3
0.42
47
456
(3015377) Calcium [Moles/volume] in Serum or Plasma
926
8980
1.04
0.53
3.2
3.4
mmol/l
2.4
2.4
1.75
794
7818
(3034274) Bile acid [Moles/volume] in Serum --fasting
23
178
1.29
0.53
2.5
1.7
umol/l
4.1
5.3
0.64
16
120
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
73
638
1.15
0.52
1.5
1.3
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
54
461
1.17
0.52
1.2
1.6
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
9
63
1.43
0.52
1.3
1.8
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
205
1900
1.08
0.52
3.1
2.9
g/l
10.1
10.6
0.97
183
1747
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
29
359
0.81
0.52
1.1
1.5
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
62
536
1.16
0.51
1.5
1.4
e6/l
23.4
31.2
0.20
50
405
(3007566) Smooth muscle Ab [Titer] in Serum
78
686
1.14
0.51
1.3
1.2
titre
268.3
89.3
—
6
55
(3006653) Thiamine [Moles/volume] in Blood
9
132
0.68
0.51
1.3
1.3
nmol/l
120.6
133.9
—
9
132
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
204
2198
0.92
0.51
3.0
2.9
ng/l
165.7
198.2
0.61
181
2010
(3015235) Bicarbonate [Moles/volume] in Capillary blood
56
650
0.86
0.51
3.9
3.3
mmol/l
24.9
25.1
0.11
50
563
(40768441) Liver Pathology biopsy report
24
188
1.28
0.51
1.3
1.3
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
30
369
0.81
0.51
1.4
1.6
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
62
537
1.16
0.51
1.6
1.4
e6/l
394.6
957.0
0.86
51
429
(3000764) Benzodiazepines [Presence] in Urine
58
500
1.16
0.50
1.2
1.6
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
6
41
1.46
0.50
1.2
1.6
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
45
380
1.19
0.50
1.5
1.3
nmol/l
0.8
0.7
0.60
40
363
(44813793)
11
156
0.70
0.49
1.0
1.1
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
11
156
0.70
0.49
1.2
1.7
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
347
3662
0.94
0.49
2.6
2.6
g/l
2.3
2.3
0.26
332
3396
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
103
926
1.12
0.49
1.6
1.6
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
12
84
1.43
0.49
1.2
1.9
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
12
167
0.72
0.49
10.1
6.6
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
46
390
1.18
0.49
1.4
1.6
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
28
345
0.81
0.49
1.1
1.1
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
27
334
0.81
0.48
1.1
1.2
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
117
1289
0.90
0.48
2.9
2.8
e6/l
0.2
0.3
0.96
110
1249
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
11
76
1.45
0.48
2.2
1.8
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
20
256
0.78
0.48
1.4
1.5
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
585
5628
1.05
0.47
4.7
4.3
%
22.5
21.5
0.88
281
2796
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
71
625
1.14
0.47
1.1
1.1
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
347
3656
0.94
0.47
2.0
2.1
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
50
581
0.86
0.47
2.1
1.7
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
14
102
1.37
0.47
1.8
1.8
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
20
255
0.78
0.46
2.0
2.0
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
24
299
0.80
0.46
1.4
1.7
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
24
299
0.80
0.46
1.0
1.1
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
17
221
0.77
0.46
1.2
1.7
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
13
176
0.74
0.46
2.3
2.0
—
—
—
0
0
(3013166) Neutrophils/100 leukocytes in Synovial fluid
5
82
0.61
0.45
1.4
1.4
%
72.3
52.9
—
5
70
(1761868) Lipid panel - Serum or Plasma
886
8612
1.04
0.45
2.9
2.9
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
22
276
0.80
0.45
1.5
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
22
276
0.80
0.45
1.5
1.4
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
1694
16669
1.04
0.45
4.6
4.6
e6/l
3000.2
2004.2
—
10
244
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
326
3434
0.94
0.45
2.7
2.7
%
22.3
22.7
0.22
289
2936
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
7
50
1.40
0.45
1.0
1.1
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
57
497
1.15
0.44
1.2
1.6
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
22
275
0.80
0.44
1.5
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
22
275
0.80
0.44
1.5
1.4
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
138
1269
1.09
0.44
1.4
1.5
—
—
—
0
0
(21494434) Karyotype in Bone marrow
29
238
1.22
0.44
1.2
1.2
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
84
753
1.12
0.44
1.7
1.7
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
308
2921
1.06
0.43
1.9
1.8
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
10
140
0.71
0.43
1.0
1.2
—
—
—
0
0
(4211845)
9
129
0.70
0.43
2.7
3.7
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
41
479
0.85
0.43
4.6
2.9
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
662
6839
0.96
0.43
3.2
3.1
—
—
—
0
0
(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
12
87
1.38
0.42
1.9
1.5
iu/ml
—
1903858.3
—
0
6
(46235355) HIV 1 and 2 tests - Meaningful Use set
316
3323
0.95
0.42
1.7
1.7
—
—
—
0
0
(3001893) Eosinophils/100 leukocytes in Pleural fluid
6
94
0.64
0.42
1.3
1.6
%
0.5
3.1
—
6
79
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
52
453
1.15
0.42
1.3
1.2
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
278
2933
0.94
0.41
7.6
7.4
mmol/l
0.9
1.1
0.37
222
2292
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
8
58
1.38
0.41
1.7
1.4
—
—
—
0
0
(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method
0
15
0.00
0.41
0.0
14.1
—
—
—
0
0
(3026029) Penicillin V IgE Ab [Units/volume] in Serum
0
16
0.00
0.41
0.0
1.1
—
0.2
—
0
6
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
8
59
1.36
0.41
1.0
1.8
—
—
—
0
0
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
0
17
0.00
0.40
0.0
7.5
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
0
18
0.00
0.40
0.0
1.0
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
0
18
0.00
0.40
0.0
1.0
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
18
0.00
0.40
0.0
2.8
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
136
1468
0.92
0.39
1.5
1.5
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
48
549
0.87
0.39
1.4
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
48
549
0.87
0.39
1.4
1.3
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
5
35
1.43
0.39
1.0
1.1
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
5
35
1.43
0.39
1.0
1.1
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
5
35
1.43
0.39
1.0
1.1
—
—
—
0
0
(3022411) Androstenedione [Moles/volume] in Serum or Plasma
0
19
0.00
0.39
0.0
1.0
—
4.9
—
0
19
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
19
151
1.26
0.38
2.6
2.3
e6/l
395.9
510.9
0.69
19
128
(40768800) Prostate Pathology biopsy report
52
457
1.14
0.38
1.2
1.2
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
280
2943
0.95
0.38
7.6
7.4
kpa
5.1
5.1
0.01
272
2815
(3008295) Osmolality of Serum or Plasma
34
289
1.18
0.38
1.8
1.3
mosm/kgh2o
277.7
277.0
0.07
29
222
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
53
467
1.14
0.38
1.4
1.4
—
—
—
0
0
(3027801) Oxygen [Partial pressure] in Arterial blood
280
2942
0.95
0.37
7.5
7.4
kpa
13.2
12.3
1.46
272
2814
(40761536) Microorganisms panel - Urine sediment
201
2133
0.94
0.37
3.8
4.1
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
419
4028
1.05
0.37
1.4
1.4
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
9
69
1.31
0.37
1.0
1.0
—
—
—
0
0
(3018418) pH of Serum or Plasma
799
7785
1.04
0.37
4.1
4.2
ph
7.4
7.4
0.30
136
1498
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
50
567
0.88
0.37
1.4
1.5
—
—
—
0
0
(3048879) Bone marrow aspiration report
10
72
1.39
0.37
1.5
1.8
—
—
—
0
0
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
10
72
1.39
0.37
2.0
2.3
ug/l
0.8
1.3
—
10
67
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
110
1192
0.92
0.36
3.6
2.6
%
1.1
1.2
0.89
110
1182
(4268621)
21
256
0.82
0.36
2.5
2.3
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
22
180
1.22
0.36
3.0
2.5
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
109
1180
0.92
0.35
1.6
1.9
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
230
2424
0.94
0.35
8.4
8.3
g/l
120.5
120.8
0.10
223
2339
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
16
126
1.27
0.35
1.0
1.0
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
41
357
1.15
0.35
1.6
1.3
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
26
309
0.84
0.35
1.9
1.7
—
—
—
0
0
(3018572) Chloride [Moles/volume] in Blood
50
564
0.88
0.35
7.8
8.6
mmol/l
106.0
105.1
0.57
44
506
(3011397) Hemoglobin [Presence] in Urine by Test strip
575
5927
0.96
0.34
3.8
3.7
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
162
1520
1.07
0.34
1.8
1.9
g/l
1.1
1.4
3.04
147
1388
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
12
156
0.77
0.34
1.2
1.7
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
79
867
0.91
0.34
2.1
2.7
—
—
—
0
0
(3039000) Anion gap in Blood
50
563
0.89
0.34
7.8
8.6
mmol/l
10.8
11.2
0.19
44
505
(3004588) Protein electrophoresis panel - Serum or Plasma
173
1837
0.94
0.34
2.2
2.6
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
45
509
0.88
0.33
1.5
1.6
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
424
4092
1.04
0.33
3.2
3.1
ug/l
0.8
0.7
0.29
273
2764
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
6
86
0.70
0.33
1.0
1.0
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
6
88
0.68
0.33
1.8
1.8
—
—
—
0
0
(3000919) Neutrophils/100 leukocytes in Pleural fluid
6
89
0.67
0.33
1.5
1.6
%
19.4
24.1
—
6
82
(1616796) Gas panel - Central venous blood
52
582
0.89
0.32
4.8
4.0
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
45
508
0.88
0.32
6.5
5.6
iu/ml
499.4
641.7
—
7
74
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
18
146
1.23
0.32
2.8
2.4
e9/l
0.2
0.2
0.16
18
128
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
18
146
1.23
0.32
1.1
1.2
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
807
8255
0.97
0.31
3.4
3.2
u/l
31.9
37.0
1.33
769
7836
(3024561) Albumin [Mass/volume] in Serum or Plasma
1138
11182
1.03
0.31
4.6
4.9
g/l
35.7
35.3
2.30
1047
10402
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
36
411
0.87
0.31
2.3
1.3
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
171
1616
1.06
0.30
1.8
1.8
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
44
390
1.13
0.30
1.2
1.7
g/l
0.8
0.8
0.01
29
296
(3021879) Hepatitis B virus core Ab [Presence] in Serum
150
1592
0.94
0.30
1.5
1.4
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
17
207
0.82
0.30
2.2
1.1
—
—
—
0
0
(3036048) Francisella tularensis Ab [Titer] in Serum
7
55
1.27
0.30
1.1
1.1
—
—
—
0
0
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
19
157
1.21
0.29
2.6
2.0
nmol/l
19.4
17.9
0.34
19
146
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
13
163
0.80
0.29
2.1
1.7
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
7
56
1.25
0.29
1.1
1.1
—
—
—
0
0
(3000012) Reticulocyte production index
10
130
0.77
0.29
1.5
1.5
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
21
249
0.84
0.29
1.5
1.4
%
24.8
32.1
0.35
14
149
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
148
1396
1.06
0.29
2.5
2.4
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
69
753
0.91
0.28
2.1
1.8
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
38
429
0.88
0.28
3.7
3.6
%
3.4
1.4
0.87
28
333
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
80
738
1.09
0.28
1.6
1.9
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
376
3636
1.04
0.28
1.2
1.2
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
1450
14687
0.98
0.28
8.8
9.2
e9/l
4.0
4.1
0.36
1246
12812
(44816559) Phosphatidylethanol [Mass/volume] in Blood
37
417
0.89
0.27
1.2
1.4
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
144
1523
0.94
0.27
1.8
1.6
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
8
65
1.23
0.27
1.3
1.1
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
26
224
1.16
0.27
1.2
1.7
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
84
779
1.08
0.26
1.3
1.4
ug/g
308.2
273.0
0.80
48
447
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
283
2938
0.96
0.26
4.4
4.3
u/l
234.4
250.1
1.61
269
2783
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
19
225
0.84
0.26
1.9
2.1
u/field
1.2
2.0
0.75
13
87
(3017354) Segmented neutrophils/100 leukocytes in Blood
22
257
0.85
0.26
4.8
3.5
%
58.9
56.3
0.33
15
163
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
77
712
1.08
0.26
1.4
1.6
g/l
0.2
0.2
0.94
70
676
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
12
95
1.26
0.26
1.0
1.0
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
251
2612
0.96
0.26
7.7
7.9
%
95.4
95.6
0.12
243
2528
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
5
71
0.70
0.26
1.2
1.1
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
954
9705
0.98
0.26
3.7
3.6
ng/l
43.3
101.9
0.66
661
6762
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
5
73
0.68
0.26
1.2
1.1
—
—
—
0
0
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
43
386
1.12
0.26
1.5
1.3
nmol/l
0.5
0.4
—
7
23
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
278
2678
1.04
0.25
1.6
1.8
%
1.4
1.5
1.41
244
2334
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
81
872
0.93
0.25
4.5
3.6
mg/l
46.5
70.4
0.63
69
708
(3027135) IgG subclass 1 [Mass/volume] in Serum
28
244
1.15
0.25
1.0
1.5
g/l
8.4
7.1
0.90
14
170
(3028192) IgG subclass 2 [Mass/volume] in Serum
28
244
1.15
0.25
1.0
1.5
g/l
2.9
2.8
0.08
13
170
(3024139) IgG subclass 3 [Mass/volume] in Serum
28
244
1.15
0.25
1.0
1.5
g/l
0.5
0.4
0.83
14
171
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
16
132
1.21
0.25
1.1
1.1
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
180
1887
0.95
0.25
1.7
1.7
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
34
383
0.89
0.25
1.1
1.1
iu/ml
2.5
1537.1
—
6
85
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
34
383
0.89
0.25
1.3
1.1
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
167
1590
1.05
0.25
2.9
3.3
pmol/l
4.4
4.4
0.00
144
1411
(1001926) Buprenorphine [Presence] in Urine by Screen method
43
387
1.11
0.25
1.2
1.5
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
9
75
1.20
0.25
1.9
1.4
ug/l
9.6
9.3
—
9
75
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
70
647
1.08
0.24
1.1
1.1
u/ml
12.3
6.3
—
7
73
(3001964) Herpes simplex virus Ag [Presence] in Specimen
9
77
1.17
0.24
1.4
1.4
—
—
—
0
0
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
16
133
1.20
0.24
1.4
1.5
pmol/l
108.4
59.9
—
7
42
(3023383) Lactate [Moles/volume] in Pleural fluid
6
82
0.73
0.24
1.3
1.4
mmol/l
3.6
3.1
—
6
72
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
214
2054
1.05
0.24
3.8
3.9
ng/l
94.5
90.9
0.18
180
1762
(3037121) Protein [Mass/volume] in Urine
95
891
1.07
0.23
2.3
3.1
g/l
0.4
0.3
0.48
38
352
(4062490)
28
246
1.14
0.23
1.1
1.5
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
14
115
1.22
0.23
2.7
4.3
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
1510
14939
1.02
0.23
4.5
4.7
mmol/l
6.7
6.7
0.17
1410
13980
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
35
313
1.12
0.23
1.2
1.1
u/ml
1.4
3.0
1.43
13
132
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
5
39
1.28
0.23
1.2
1.2
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
1248
12325
1.02
0.22
5.1
5.1
estimate
0.0
0.0
0.50
208
2287
(3000475) Leukocytes [#/volume] in Synovial fluid
68
631
1.08
0.22
1.7
1.7
e6/l
9478.8
13778.3
0.73
50
454
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
101
1071
0.94
0.22
1.8
1.9
u/l
40.6
39.1
0.29
88
949
(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
7
95
0.74
0.22
1.1
2.4
—
33526.1
—
0
15
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
7
95
0.74
0.22
1.0
1.1
miu/ml
734.3
1631.9
—
7
95
(3024932) HLA-DR beta [Type]
10
79
1.27
0.22
1.2
1.1
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
10
79
1.27
0.22
1.6
2.2
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
5
41
1.22
0.22
1.2
1.1
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
15
178
0.84
0.22
1.3
1.3
u/ml
0.4
1.1
—
10
86
(3009261) Glucose [Presence] in Urine by Test strip
1262
12471
1.02
0.21
3.7
3.8
estimate
0.0
0.0
1.06
205
2232
(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma
0
11
0.00
0.21
0.0
1.3
—
2.5
—
0
11
(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
394
3838
1.03
0.21
1.9
2.1
s
29.8
29.8
0.05
385
3731
(1175426) CD3 cells/100 lymphocytes in Blood
21
182
1.15
0.21
2.1
2.0
%
74.0
72.4
0.37
21
170
(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3030313) Adrenal Ab [Titer] in Serum
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3038864) risperiDONE [Moles/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.7
—
13.1
—
0
12
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
8
103
0.78
0.21
1.4
1.1
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
120
1140
1.05
0.21
1.5
1.8
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
5
43
1.16
0.21
1.0
1.5
ng/l
68.0
119.1
—
5
43
(3037297) Penicillin G IgE Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.1
—
0.1
—
0
5
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
11
134
0.82
0.20
1.1
1.6
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
11
134
0.82
0.20
1.1
1.6
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
50
460
1.09
0.20
1.3
1.2
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
26
230
1.13
0.20
2.4
2.2
e9/l
0.9
1.1
0.58
14
142
(3020630) Protein [Mass/volume] in Serum or Plasma
213
2208
0.96
0.20
2.1
2.9
g/l
66.3
66.5
0.13
187
2021
(3034860) Kappa light chains.free [Mass/volume] in Serum
82
872
0.94
0.20
4.5
3.6
mg/l
39.2
58.8
1.30
70
709
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
40
364
1.10
0.20
1.3
1.2
u/ml
2.9
5.0
1.01
17
152
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3013762) Body weight Measured
0
14
0.00
0.20
0.0
1.3
—
—
—
0
0
(3027570) Oxalate [Moles/time] in 24 hour Urine
0
14
0.00
0.20
0.0
1.6
—
367.5
—
0
14
(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose
0
14
0.00
0.20
0.0
1.1
—
7.7
—
0
14
(3011648) Oxygen content in Venous blood
18
208
0.86
0.20
2.6
1.9
%
10.1
11.0
0.44
18
208
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
789
8016
0.98
0.20
2.4
2.6
u/l
58.2
57.9
0.06
725
7396
(3038071) Oxygen [Partial pressure] in Mixed venous blood
6
50
1.20
0.19
4.0
8.4
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
1274
12603
1.02
0.19
5.7
5.9
e9/l
0.0
0.0
0.35
1097
10861
(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis
11
90
1.22
0.19
1.0
1.7
pmol/l
16.3
15.0
0.26
11
76
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
51
472
1.08
0.19
1.4
1.4
—
15.8
—
0
9
(3036481) Cortisol [Moles/volume] in Serum or Plasma
225
2325
0.97
0.19
2.4
2.2
nmol/l
349.6
370.3
0.94
207
2130
(3042631) Mycobacterium sp identified in Specimen
40
366
1.09
0.19
2.2
2.7
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
43
395
1.09
0.18
1.1
1.0
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
15
175
0.86
0.18
1.5
1.3
mmol/l
12.2
12.5
—
6
55
(3003888) Timothy IgE Ab [Units/volume] in Serum
35
318
1.10
0.18
1.0
1.1
u/ml
0.8
3.4
2.81
17
145
(3024471) HLA-A [Type]
10
81
1.24
0.18
1.0
1.0
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
80
848
0.94
0.18
4.0
3.5
ratio
12.6
1.3
—
7
64
(3017446) Testosterone [Moles/volume] in Serum or Plasma
148
1420
1.04
0.18
2.5
2.2
nmol/l
12.5
12.6
0.03
130
1242
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
23
259
0.89
0.18
4.3
4.0
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
815
8033
1.02
0.18
3.1
3.1
mmol/l
7.4
7.2
0.46
671
6737
(40760888) Immunoglobulin light chains.free panel - Serum
61
652
0.93
0.18
5.0
3.8
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
22
248
0.89
0.18
2.7
2.9
—
—
—
0
0
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
10
121
0.83
0.18
1.2
2.3
%
102.9
96.7
—
10
112
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
10
121
0.83
0.18
2.3
2.6
u/ml
850.5
1185.3
—
10
121
(3002256) Pathology report gross observation
350
3417
1.03
0.17
1.2
1.3
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
26
289
0.90
0.17
3.5
3.5
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
49
527
0.93
0.17
1.8
1.7
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
7
62
1.13
0.17
1.0
1.6
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
64
601
1.07
0.17
1.5
1.4
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
930
9416
0.98
0.17
3.9
4.0
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
51
547
0.93
0.17
2.5
2.6
%
16.9
16.0
0.84
27
285
(3022948) Iron [Moles/volume] in Serum or Plasma
390
3984
0.98
0.16
2.5
2.6
umol/l
13.4
13.0
0.65
370
3696
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
70
741
0.94
0.16
1.3
2.5
g/l
0.0
0.0
0.00
62
684
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
424
4326
0.98
0.16
2.8
2.7
e6/l
2.0
1.2
0.42
237
2465
(3044242) Glucose [Moles/volume] in Arterial blood
12
141
0.85
0.16
3.6
2.2
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
8
70
1.14
0.16
1.3
1.1
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
30
329
0.91
0.16
1.6
1.5
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
71
671
1.06
0.16
1.8
1.7
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
46
494
0.93
0.16
1.6
1.3
mmol/l
75.2
61.1
0.94
32
397
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
612
6216
0.98
0.16
2.2
2.3
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
21
235
0.89
0.16
2.8
2.4
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
249
2424
1.03
0.16
2.1
2.4
u/l
36.2
59.1
0.60
221
2087
(44806420)
6
78
0.77
0.15
3.0
2.4
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
6
78
0.77
0.15
1.2
1.1
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
6
79
0.76
0.15
1.2
1.1
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
36
332
1.09
0.15
1.4
1.5
%
51.9
59.3
0.43
25
209
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
20
178
1.12
0.15
2.1
2.0
%
13.9
13.3
—
7
71
(3047181) Lactate [Moles/volume] in Blood
75
789
0.95
0.15
6.2
7.3
mmol/l
1.7
1.3
0.77
65
687
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
46
492
0.93
0.15
1.1
1.2
—
273.3
—
0
12
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
163
1578
1.03
0.14
3.8
3.8
kpa
5.2
5.2
0.27
149
1464
(3045683) HLA typing for celiac disease panel - Blood or Tissue
15
131
1.15
0.14
1.0
1.0
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
695
7041
0.98
0.14
3.2
3.1
e6/l
0.3
0.5
1.25
508
5308
(3024263) Appearance of Synovial fluid
12
139
0.86
0.14
1.8
2.0
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
1315
13046
1.01
0.14
6.0
6.1
e9/l
0.2
0.2
0.08
1143
11409
(3014148) Varicella zoster virus Ab [Titer] in Serum
27
247
1.09
0.13
1.1
1.2
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
410
4029
1.02
0.13
2.9
2.9
e6/l
3.5
2.9
0.32
218
2182
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
113
1172
0.96
0.13
1.6
1.8
g/l
1.7
1.6
0.47
99
1009
(3000330) Specific gravity of Urine by Test strip
129
1334
0.97
0.13
3.6
3.4
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
9
106
0.85
0.13
1.0
1.2
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
70
734
0.95
0.13
1.3
2.5
g/l
0.0
0.0
0.00
62
683
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
16
142
1.13
0.12
1.1
1.1
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
34
316
1.08
0.12
2.3
2.5
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
44
414
1.06
0.12
1.4
1.4
u/ml
115.5
120.8
—
10
80
(3020717) Zinc [Moles/volume] in Serum or Plasma
15
133
1.13
0.12
1.0
1.4
umol/l
21.1
23.4
0.12
15
125
(3019832) Treponema pallidum Ab [Presence] in Serum
130
1341
0.97
0.12
1.5
1.6
—
—
—
0
0
(3009343) pH of Capillary blood
160
1557
1.03
0.11
3.9
3.8
ph
7.4
7.4
1.90
23
208
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
40
376
1.06
0.11
1.2
1.2
u/ml
1.5
3.6
1.39
17
124
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
502
4953
1.02
0.11
3.3
3.6
ng/l
290.5
412.0
0.68
383
3914
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
149
1449
1.03
0.11
1.7
1.7
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
45
425
1.06
0.11
1.3
1.2
u/ml
278.9
274.2
0.04
32
257
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
180
1756
1.03
0.11
1.3
1.3
—
—
—
0
0
(40768793) Breast Pathology biopsy report
65
679
0.96
0.11
1.3
1.3
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
101
977
1.03
0.10
2.0
1.8
—
—
—
0
0
(3008037) Lactate [Moles/volume] in Venous blood
58
554
1.05
0.10
2.7
3.1
mmol/l
1.8
1.5
0.33
58
538
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
26
280
0.93
0.10
1.4
1.5
nmol/l
0.3
0.3
0.23
19
204
(3045424) Erythrocytes [Presence] in Urine
47
447
1.05
0.10
1.4
1.6
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
1296
12885
1.01
0.09
5.8
6.0
e9/l
1.9
1.9
0.41
1134
11304
(3044927) Protein electrophoresis panel - Urine
30
281
1.07
0.09
1.5
1.2
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
48
503
0.95
0.09
3.1
3.0
—
—
—
0
0
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
158
1616
0.98
0.09
9.1
8.8
%
0.7
0.7
0.35
158
1604
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
48
458
1.05
0.09
1.6
1.9
u/l
520.9
2429.8
2.04
20
178
(3026389) Candida sp identified in Specimen by Organism specific culture
34
360
0.94
0.09
1.2
1.4
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
24
223
1.08
0.09
1.6
1.5
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
86
888
0.97
0.09
2.2
2.2
ug/l
228.4
751.2
1.50
75
836
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
76
734
1.04
0.09
1.4
1.6
g/l
1.2
1.2
0.29
70
699
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
11
97
1.13
0.09
1.9
2.0
ug/l
20.5
17.8
0.20
11
86
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
153
1496
1.02
0.09
3.7
3.7
mmol/l
1.4
1.9
1.14
118
1136
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
21
194
1.08
0.09
1.6
1.5
g/l
1.0
1.0
0.15
21
194
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
6
55
1.09
0.09
4.0
8.2
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
29
308
0.94
0.08
1.3
1.4
—
—
—
0
0
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
10
113
0.88
0.08
1.2
1.1
u/ml
—
11.2
—
0
13
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
297
2928
1.02
0.08
2.6
2.7
umol/l
7.2
7.8
0.22
253
2551
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
41
430
0.95
0.08
1.2
1.3
u/l
40.9
37.3
0.08
31
370
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
5
62
0.81
0.08
1.0
1.1
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
5
65
0.77
0.08
1.0
1.6
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
1262
12555
1.01
0.08
5.7
5.9
e9/l
0.6
0.6
0.50
1083
10810
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
54
519
1.04
0.08
2.9
3.8
%
56.4
57.3
0.22
54
519
(3024928) Oxygen saturation in Venous blood
51
531
0.96
0.08
3.7
2.9
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
17
156
1.09
0.08
1.1
1.0
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
545
5501
0.99
0.08
1.7
1.8
mg/l
1.6
1.2
0.49
410
4252
(21494890) Protein electrophoresis panel - 24 hour Urine
28
297
0.94
0.08
3.0
2.1
—
—
—
0
0
(4306422)
38
362
1.05
0.07
1.3
1.2
—
—
—
0
0
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
6
70
0.86
0.07
1.2
1.1
%
114.3
104.4
—
6
62
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
74
0.81
0.07
1.2
1.1
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
28
264
1.06
0.07
2.4
1.7
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
6
75
0.80
0.07
2.2
1.7
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
6
75
0.80
0.07
1.2
1.1
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
87
846
1.03
0.07
1.4
1.6
—
371.2
—
0
41
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
21
225
0.93
0.07
1.4
1.2
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
8
75
1.07
0.07
5.4
5.4
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
428
4237
1.01
0.07
3.5
3.4
mmol/l
0.8
0.8
0.38
402
3958
(3006245) CD3-CD19+ cells/100 cells in Blood
7
82
0.85
0.07
2.7
2.2
%
7.9
9.4
—
7
74
(3034426) Prothrombin time (PT)
7
82
0.85
0.07
1.3
1.2
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
23
245
0.94
0.07
6.0
4.9
u/ml
639.8
49.6
—
8
70
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
73
752
0.97
0.07
2.1
2.0
%
92.9
90.4
0.49
67
707
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
26
245
1.06
0.07
1.2
1.1
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
61
590
1.03
0.07
1.9
1.6
mu/l
301.9
308.4
0.07
55
535
(3002032) Base excess in Venous blood by calculation
227
2303
0.98
0.07
4.1
3.8
mmol/l
2.0
2.0
0.00
182
1888
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
72
699
1.03
0.07
1.2
1.2
—
—
—
0
0
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
160
1628
0.98
0.06
8.9
8.7
%
1.2
1.3
1.29
160
1619
(3008757) Leukocyte morphology finding [Identifier] in Blood
27
285
0.95
0.06
3.2
4.3
—
—
—
0
0
(3020491) Glucose [Moles/volume] in Blood
19
177
1.07
0.06
1.3
2.1
mmol/l
6.1
7.0
1.47
13
108
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
17
183
0.93
0.06
1.0
1.0
ng/l
553.4
314.5
—
10
117
(40765096) Chromosome analysis panel by Banding
11
99
1.11
0.06
1.3
1.1
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
9
101
0.89
0.06
1.2
1.4
—
—
—
0
0
(4035726)
241
2440
0.99
0.06
1.3
1.4
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
44
424
1.04
0.06
1.8
1.4
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
30
286
1.05
0.06
1.0
1.1
u/ml
0.6
1.7
—
8
70
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
77
751
1.03
0.06
1.3
1.3
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
231
2282
1.01
0.05
6.5
7.8
mmol/l
8.8
10.1
2.14
223
2184
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
25
237
1.06
0.05
2.4
1.6
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
25
237
1.06
0.05
2.4
1.6
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
25
237
1.06
0.05
2.4
1.6
—
—
—
0
0
(4027681)
14
129
1.09
0.05
1.3
1.1
—
—
—
0
0
(3003338) MCHC [Mass/volume]
2084
20884
0.99
0.05
18.0
19.0
g/l
332.2
331.7
1.78
2068
20729
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
1353
13484
1.01
0.05
6.1
6.3
umol/l
11.3
11.3
0.00
1281
12811
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
101
990
1.02
0.05
1.9
2.5
g/l
3.1
3.1
0.15
73
782
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
288
2851
1.01
0.05
3.8
4.1
ug/l
21.2
22.6
0.04
244
2314
(40758558) Short blood count panel - Blood
658
6543
1.01
0.05
6.4
6.8
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
21
222
0.95
0.05
1.0
1.0
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
107
1051
1.02
0.05
1.8
2.5
g/l
3.7
3.8
0.52
71
764
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
557
5604
0.99
0.05
1.6
1.7
pmol/l
48655131.7
33599572.1
0.22
446
4640
(3052851) Hemolysis interference index of Serum or Plasma
80
783
1.02
0.05
3.1
3.5
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
81
827
0.98
0.04
1.3
2.4
g/l
38.4
37.7
0.48
65
715
(3007930) Methemoglobin/Hemoglobin.total in Blood
104
1022
1.02
0.04
5.3
6.1
%
0.9
0.9
0.41
98
958
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
46
474
0.97
0.04
1.9
1.7
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
107
1052
1.02
0.04
1.8
2.5
g/l
7.6
7.4
0.38
75
802
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
107
1052
1.02
0.04
1.8
2.5
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
327
3244
1.01
0.04
6.9
7.0
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
1232
12283
1.01
0.04
3.7
3.8
estimate
0.0
0.0
0.00
198
2248
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
32
332
0.96
0.04
1.5
1.7
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
105
1067
0.98
0.04
2.4
1.9
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
92
904
1.02
0.04
1.8
2.6
g/l
0.4
1.0
1.42
74
790
(3042111) Morphology [Interpretation] in Bone marrow Narrative
48
467
1.03
0.04
1.5
1.6
—
—
—
0
0
(3026782) Osmolality of Urine
501
4982
1.01
0.04
3.1
2.8
mosm/kgh2o
543.5
538.5
0.19
426
4233
(3048929) Epstein Barr virus Ab [Presence] in Serum
64
626
1.02
0.04
1.3
1.2
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
39
378
1.03
0.04
1.3
1.3
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
20
190
1.05
0.04
1.3
1.1
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
20
190
1.05
0.04
1.0
1.3
—
—
—
0
0
(4146454)
28
291
0.96
0.04
2.5
2.6
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
14
131
1.07
0.03
3.8
2.4
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
14
131
1.07
0.03
2.2
3.6
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
24
230
1.04
0.03
1.0
1.1
u/ml
0.9
3.0
—
10
88
(3013139) Helicobacter pylori Ag [Presence] in Stool
172
1737
0.99
0.03
1.3
1.3
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
17
161
1.06
0.03
1.5
1.2
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
269
2709
0.99
0.03
3.0
3.5
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
84
853
0.98
0.03
1.3
1.4
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
490
4878
1.01
0.03
3.1
3.0
mmol/l
2.5
2.5
0.92
432
4280
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
11
118
0.93
0.02
2.4
2.4
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
13
138
0.94
0.02
1.5
1.2
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
99
978
1.01
0.02
1.8
2.5
g/l
10.1
10.3
0.29
76
838
(3008401) Mugwort IgE Ab [Units/volume] in Serum
30
309
0.97
0.02
1.0
1.1
u/ml
0.3
1.4
—
9
119
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
87
859
1.01
0.02
1.7
1.7
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
73
740
0.99
0.02
1.6
1.6
iu/ml
0.0
9.2
0.58
14
148
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
28
272
1.03
0.02
1.0
1.1
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
29
282
1.03
0.02
2.3
1.7
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
11
103
1.07
0.02
1.1
1.3
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
17
163
1.04
0.01
1.5
1.2
—
—
—
0
0
(3015736) pH of Urine
956
9575
1.00
0.01
3.4
3.5
—
5.9
—
0
6
(3051651) Icteric interference index of Serum or Plasma
16
167
0.96
0.01
3.2
3.7
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
96
969
0.99
0.01
3.9
3.5
u/ml
32.9
4428.9
0.90
84
822
(3012516) Albumin [Mass/volume] in Urine
771
7724
1.00
0.01
3.2
3.2
mg/l
370.5
324.9
0.10
455
4776
(3020682) Albumin/Creatinine [Ratio] in Urine
815
8136
1.00
0.01
3.8
4.0
mg/mmol
7.7
9.0
0.29
484
5027
(1761482) Bacteria [#/volume] in Urine by Culture
66
668
0.99
0.01
5.0
4.4
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
39
383
1.02
0.01
1.6
1.7
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
137
1362
1.01
0.01
9.4
10.5
—
—
—
0
0
(3038515) Glucose [Moles/volume] in Venous blood
53
523
1.01
0.01
2.8
3.2
mmol/l
7.3
7.5
0.29
53
510
(3005322) IgE [Units/volume] in Serum or Plasma
150
1508
0.99
0.01
1.3
1.3
u/ml
162.6
203.1
0.58
137
1382
(3041096) Erythrocytes [Presence] in Urine by Automated
651
6519
1.00
0.01
3.4
3.5
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
12
114
1.05
0.00
1.1
1.1
—
—
—
0
0
(3017704) Immunofixation for Urine
16
154
1.04
0.00
2.7
1.6
—
—
—
0
0
(3000991) Gas panel - Venous blood
209
2083
1.00
0.00
9.2
8.4
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
36
366
0.98
0.00
1.1
1.1
u/ml
0.3
1.8
2.05
14
138
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
36
366
0.98
0.00
1.2
1.1
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
117
1176
0.99
0.00
4.6
4.1
mmol/l
24.1
24.2
0.06
110
1055
(3019977) pH of Arterial blood
14
135
1.04
0.00
4.1
3.0
ph
7.5
7.4
—
6
47
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
18
185
0.97
0.00
1.0
1.0
ng/l
61.9
45.2
0.59
11
115
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
19
195
0.97
0.00
1.2
1.1
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
24
235
1.02
0.00
2.3
1.6
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
25
245
1.02
0.00
1.1
1.1
u/ml
0.6
2.4
—
9
92
(3004451) EKG impression Narrative
14
139
1.01
0.00
1.3
1.3
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
14
141
0.99
0.00
2.5
1.7
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
29
285
1.02
0.00
1.1
1.3
mmol/l
7.5
7.4
0.00
20
212
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
16
161
0.99
0.00
1.1
1.2
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
25
251
1.00
0.00
1.4
1.3
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
35
349
1.00
0.00
1.1
1.1
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
39
389
1.00
0.00
1.1
1.0
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
56
561
1.00
0.00
2.0
2.3
g/l
132.9
128.4
0.63
36
411
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
103
1035
0.99
0.00
5.3
6.0
%
1.4
1.6
1.17
97
969
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
11
114
0.96
0.00
8.8
11.3
mmol/l
0.5
0.6
0.70
11
106
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
11
114
0.96
0.00
1.9
2.5
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
11
114
0.96
0.00
3.2
2.9
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
24
244
0.98
0.00
1.4
1.2
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
10
98
1.02
0.00
3.4
2.3
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
10
102
0.98
0.00
1.4
2.3
%
122.6
157.2
—
10
94
(3044889) 12 lead EKG panel
1818
18175
1.00
0.00
3.9
3.8
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
17
172
0.99
0.00
1.4
1.5
—
—
—
0
0
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
20
198
1.01
0.00
1.2
1.2
titre
68.0
117.9
—
5
38
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
79
794
0.99
0.00
1.4
2.5
g/l
0.0
0.0
0.00
71
733
(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
22
222
0.99
0.00
2.8
1.9
mg/l
2.9
4.2
1.97
22
216
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
22
222
0.99
0.00
1.1
1.1
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
24
242
0.99
0.00
1.3
1.5
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
31
308
1.01
0.00
1.7
1.8
ug/l
19.4
24.1
0.45
31
302
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
748
7484
1.00
0.00
2.9
3.0
ng/l
1487.1
1405.6
0.11
619
6438
(3021589) Normoblasts [#/volume] in Blood
1121
11214
1.00
0.00
9.8
9.8
e9/l
0.0
0.0
1.19
922
9132
(3009214) Lutropin [Units/volume] in Serum or Plasma
46
463
0.99
0.00
1.5
1.3
u/l
12.7
12.0
0.11
35
368
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
18
183
0.98
0.00
1.0
1.0
ng/l
496.5
707.2
—
10
115
(3002568) Complement factor B [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
0.2
—
0
6
(3012989) Citrate [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.3
—
2.1
—
0
6
(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.2
—
1.3
—
0
6
(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3043722) Hyaline casts [#/area] in Urine sediment by Automated count
0
6
0.00
0.00
0.0
1.0
—
1.2
—
0
6
(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3033093) Yersinia sp IgM Ab [Titer] in Serum
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(36303858) Crystals [Presence] in Urine
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042301) Urate [Moles/volume] in Synovial fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40769427) Triglyceride [Moles/volume] in Peritoneal fluid
0
6
0.00
0.00
0.0
1.5
—
3513.3
—
0
6
(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004347) Hepatitis D virus Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3049242) von Willebrand panel - Platelet poor plasma
0
6
0.00
0.00
0.0
3.3
—
—
—
0
0
(3046682) IgA [Presence] in Skin by Immunofluorescence
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3041184) Isoniazid [Presence] in Urine
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
22
220
1.00
0.00
1.1
1.3
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
7
73
0.96
0.00
1.7
2.9
—
—
—
0
0
(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma
8
85
0.94
0.00
1.1
1.3
umol/l
3.9
3.9
—
8
79
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
8
89
0.90
0.00
1.3
1.1
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
9
92
0.98
0.00
2.0
1.7
—
—
—
0
0
(3006576) Bicarbonate [Moles/volume] in Blood
7
79
0.89
0.00
3.6
7.6
mmol/l
26.3
24.8
—
7
74
(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
7
75
0.93
0.00
1.1
1.1
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
7
73
0.96
0.00
1.7
2.9
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
5
56
0.89
0.00
2.4
2.5
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
5
52
0.96
0.00
1.0
1.1
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
8
89
0.90
0.00
1.6
1.2
—
—
—
0
0
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
17
170
1.00
0.00
1.2
1.1
mg/l
31.4
43.4
0.97
12
146
(3003531) Amoxicillin IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
5
54
0.93
0.00
4.8
3.0
—
—
—
0
0
(3006567) Chloride [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.5
—
2.1
—
0
8
(4038314)
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
5
59
0.85
0.00
1.0
1.2
—
—
—
0
0
(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000690) Aldosterone [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.0
—
25.8
—
0
5
(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood
7
79
0.89
0.00
2.7
2.2
%
20.3
28.9
—
7
71
(3010937) Rubella virus Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
11
110
1.00
0.00
1.3
1.2
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
6
60
1.00
0.00
1.0
1.3
—
—
—
0
0
(3041672) Baker's yeast Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022229) Phosphate [Moles/volume] in Urine
0
5
0.00
0.00
0.0
3.4
—
14.6
—
0
5
(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay
7
78
0.90
0.00
1.6
2.4
%
124.7
174.8
—
7
70
(3000060) B lymphocytes [#/volume] in Blood
5
56
0.89
0.00
3.0
2.0
e6/l
80.0
141.2
—
5
25
(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint H8_OTOSCLE and mortality.

Females

Parameter HR [95% CI] p-value
H8_OTOSCLE 0.764 [0.69, 0.85] < 0.001
Birth year 0.991 [0.98, 1.0] 0.047

During the follow-up period (1.1.1998 — 31.12.2019), 728 out of 7721 females with H8_OTOSCLE died.

Males

Parameter HR [95% CI] p-value
H8_OTOSCLE 0.687 [0.62, 0.76] < 0.001
Birth year 0.992 [0.98, 1.0] 0.07

During the follow-up period (1.1.1998 — 31.12.2019), 547 out of 4710 males with H8_OTOSCLE died.

Mortality risk

Mortality risk for people of age

years, who have H8_OTOSCLE.

N-year risk Females Males
1 0.069% 0.179%
5 0.418% 0.94%
10 1.008% 2.26%
15 1.966% 4.465%
20 3.456% 7.889%

Relationships between endpoints

↥

Index endpoint: H8_OTOSCLE – Otosclerosis

GWS hits: 40

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data